Delphia Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Kendall Sq Bldg 200 Ste 1, Cambridge, ...Website
www.delphiatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Delphia Therapeutics
Based out of Cambridge, MA, Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphias activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.Explore more
Delphia Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Delphia Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Delphia Therapeutics
Check out if Delphia Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Delphia Therapeutics recently announced quarterly report
Click to see if Delphia Therapeutics had a recent Job posting/layoffs
Delphia Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Delphia Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Delphia Therapeutics launches new products
Funding: Get notified immidiatlly once Delphia Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Delphia Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Delphia Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Delphia Therapeutics.
Delphia Therapeutics financials insights
Gather financial insights about Delphia Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$67M
Delphia Therapeutics Tech Stack
A closer look at the technologies used by Delphia Therapeutics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Delphia Therapeutics News & Media
Delphia Therapeutics Scores $67 Series A
CAMBRIDGE, MA, Delphia Therapeutics announced its launch and $67 million Series A financing.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Delphia Therapeutics
Sign Up For FreeTo access detailed company insights
Based out of Cambridge, MA, Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphias activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their... Read More
